Marker Therapeutics, Inc. Announces Proposed Public Offering of Common Stock ...Middle East

HOUSTON, March 11, 2021 /PRNewswire/ -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today...

Hence then, the article about marker therapeutics inc announces proposed public offering of common stock was published today ( Friday 12/03/2021 - 12:31 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Marker Therapeutics, Inc. Announces Proposed Public Offering of Common Stock )

Also on site :

• Yolo County fire prompts evacuations, closes southbound I-5 near Dunnigan
• Trump expects Nato allies to honour defence spending pledges, White House says
• What Comcast-NBCUniversal Split Faces On D.C.’s Trump-Influenced Regulatory Road